Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model-Reference-Cited by-同舟云学术

Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model

Published:2009-02 Issue:1 Volume:134 Page:18-25
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Abu-Lila Amr,Suzuki Takuya,Doi Yusuke,Ishida Tatsuhiro,Kiwada Hiroshi

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference41 articles.

1. Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4 dihydroxyphenylalanine;Nishikawa;Eur. J. Pharmacol.,2006

2. Antitumor effect of kigamicin D on mouse tumor models;Masuda;J. Antibiot. (Tokyo),2006

3. Gamma-hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor;Basaki;Angiogenesis,2001

4. Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data;Tashiro;Biomed. Pharmacother.,1989

5. UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice;Yonekura;Clin. Cancer Res.,1999

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platinum-based chemotherapy: trends in organic nanodelivery systems;Nanoscale;2024

2. Selective Protein of Interest Degradation through the Split-and-Mix Liposome Proteolysis Targeting Chimera Approach;Journal of the American Chemical Society;2023-09-14

3. Doxorubicin-loaded liposomes surface engineered with the matrix metalloproteinase-2 cleavable polyethylene glycol conjugate for cancer therapy;Cancer Nanotechnology;2023-03-07

4. Oral administration of sodium bicarbonate can enhance the therapeutic outcome of Doxil® via neutralizing the acidic tumor microenvironment;Journal of Controlled Release;2022-10

5. The Challenge to Deliver Oxaliplatin (l-OHP) to Solid Tumors: Development of Liposomal l-OHP Formulations;Chemical and Pharmaceutical Bulletin;2022-05-01